GLP‑1 Medications & Cravings: How Ozempic & Wegovy Reduce Urges

How do GLP-1 medications reduce cravings? GLP-1 medications and cravings explained, including semaglutide (Ozempic, Wegovy).GLP-1 receptor agonists are prescription medicines used for type 2 diabetes and weight management. They mimic the hormone glucagon-like peptide-1, affecting appetite regulation, gastric emptying, and reward pathways in the brain. This episode explains how these medications may reduce food urges and what patients should understand before treatment.You will learn:• How GLP-1 receptor agonists influence appetite and satiety signals• The role of delayed gastric emptying in reducing hunger• Differences between Ozempic (type 2 diabetes) and Wegovy (weight management indications)• Common side effects (nausea, vomiting, gastrointestinal symptoms)• Potential risks and contraindications (history of pancreatitis, certain endocrine conditions)• Why medical screening and ongoing monitoring are requiredWe also outline how suitability for GLP-1 therapy is medically assessed, including BMI criteria, metabolic history, medication interactions, and red-flag screening.This episode is educational and does not replace specialist or urgent medical care where required.Read the full clinical guide and transcript here:https://www.mobidoctor.eu/blog/glp1-medications-cravings-how-ozempic-wegovy-reduce-urges